Ping Chen

US Patent:

6385748, May 7, 2002

Filed:

Mar 30, 1999

Appl. No.:

09/281370

Inventors:

Ping Chen - San Jose CA

Assignee:

NEC Electronics, Inc. - Santa Clara CA

International Classification:

G01R 3128

US Classification:

714724, 365201

Abstract:

A method and circuit for allowing direct access logic testing in integrated circuits. In one embodiment, an interface between integrated circuit core logic and integrated circuit user-defined logic is exposed, and the integrated circuit core logic and the integrated circuit user-defined logic is tested via the exposed interface. In another embodiment, an integrated circuit has logic selection circuitry connected with core logic and user-defined logic. The logic selection circuitry is used to selectively test the core logic and user-defined logic.

US Patent:

6596746, Jul 22, 2003

Filed:

Apr 13, 2000

Appl. No.:

09/548929

Inventors:

Jagabandhu Das - Mercerville NJ
Ramesh Padmanabha - Hamden CT
Ping Chen - Belle Mead NJ
Derek J. Norris - Trenton NJ
Arthur M. P. Doweyko - Long Valley NJ
Joel C. Barrish - Holland PA
John Wityak - Robbinsville NJ

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D27742

US Classification:

514370, 548194

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

US Patent:

6979694, Dec 27, 2005

Filed:

Mar 3, 2003

Appl. No.:

10/378372

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ramesh Padmanabha - Hamden CT, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US
Arthur M. P. Doweyko - Long Valley NJ, US
Joel C. Barrish - Holland PA, US
John Wityak - Robbinsville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K031/426
A61K031/44
C07D277/20
C07D417/12

US Classification:

514342, 514371, 5462707, 548195, 544106, 544133

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

US Patent:

7091223, Aug 15, 2006

Filed:

Mar 3, 2003

Appl. No.:

10/378461

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ramesh Padmanabha - Hamden CT, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US
Arthur M. P. Doweyko - Long Valley NJ, US
Joel C. Barrish - Holland PA, US
John Wityak - Robbinsville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K 31/4439
C07D 417/12

US Classification:

514342, 5462707

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

US Patent:

7125875, Oct 24, 2006

Filed:

Mar 24, 2003

Appl. No.:

10/395503

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ramesh Padmanabha - Hamden CT, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US
Arthur M. P. Doweyko - Long Valley NJ, US
Joel C. Barrish - Richboro PA, US
John Wityak - Robbinsville NJ, US
Louis J. Lombardo - Belle Mead NJ, US
Francis Y. F. Lee - Yardley PA, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K 31/427
A61K 31/496
A61K 31/501

US Classification:

51425219, 514370

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

US Patent:

7153856, Dec 26, 2006

Filed:

May 26, 2005

Appl. No.:

11/138942

Inventors:

Joel C. Barrish - Richboro PA, US
John Wityak - Carlsbad CA, US
Jagabandhu Das - Mercerville NJ, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Pennington NJ, US
Gary Schieven - Lawrenceville NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

A61K 31/497
C07D 241/02

US Classification:

51425211, 544357

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

US Patent:

7189854, Mar 13, 2007

Filed:

May 26, 2005

Appl. No.:

11/138793

Inventors:

Jagabandhu Das - Mercerville NJ, US
Ping Chen - Belle Mead NJ, US
Derek J. Norris - Trenton NJ, US

Assignee:

Bristol-Myers Squibb Company - Princeton NJ

International Classification:

C07D 401/00
C07D 233/44

US Classification:

5462701, 5483321

Abstract:

Novel cyclic compounds and salts thereof, pharmaceutical compositions containing such compounds, and methods of using such compounds in the treatment of protein tyrosine kinase-associated disorders such as immunologic and oncologic disorders.

US Patent:

7325086, Jan 29, 2008

Filed:

Dec 15, 2005

Appl. No.:

11/300980

Inventors:

Roy (Dehai) Kong - Cupertino CA, US
Wen-Chung Chen - Cupertino CA, US
Ping Chen - San Jose CA, US
Irene (Chih-Yiieh) Cheng - San Jose CA, US
Tatsang Mak - Milpitas CA, US
Xi Liu - Shanghai, CN
Li Zhang - ShangHai, CN
Li Sun - Shanghai, CN
Chenggang Liu - Shanghai, CN

Assignee:

Via Technologies, Inc. - Hsin-Tien, Taipei

International Classification:

G06F 13/40

US Classification:

710307, 345503

Abstract:

Supporting multiple graphics processing units (GPUs) comprises a first path coupled to a north bridge device (or a root complex device) and a first GPU, which may include a portion of the first GPU's total communication lanes. A second communication path may be coupled to the north bridge device and a second GPU and may include a portion of the second GPU's total communication lanes. A third communication path may be coupled between the first and second GPUs directly or through one or more switches that can be configured for single or multiple GPU operations. The third communication path may include some or all of the remaining communication lanes for the first and second GPUs. As a nonlimiting example, the first and second GPUs may each utilize an 8-lane PCI express communication path with the north bridge device and an 8-lane PCI express communication path with each other.

Address:

1971 Hastings Ct, Santa Clara, CA 95051

Phone:

4083986852

VIN:

2HNYD2H27CH501356

Make:

ACURA

Model:

MDX

Year:

2012